Submitted by Anonymous (not verified) on 6 February 2026 - 15:00
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 6, Status: Authorised